Compounds > cabergoline
Page last updated: 2024-08-23

cabergoline and Constrictive Pericarditis

cabergoline has been researched along with Constrictive Pericarditis in 4 studies

Research

Studies (4)

TimeframeStudies, this research(%)All Research%
pre-19900 (0.00)18.7374
1990's1 (25.00)18.2507
2000's3 (75.00)29.6817
2010's0 (0.00)24.3611
2020's0 (0.00)2.80

Authors

AuthorsStudies
MacIver, DH; Townsend, M1
Andreasen, JJ; Hjortshøj, SP; Poulsen, SH1
Katzman, P; Lindgren, H; Löndahl, M; Nilsson, A1
Ahlskog, JE; Limper, AH; Ling, LH; Munger, TM; Oh, JK1

Other Studies

4 other study(ies) available for cabergoline and Constrictive Pericarditis

ArticleYear
Constrictive pericarditis and pleuropulmonary fibrosis secondary to cabergoline treatment for Parkinson's disease.
    Heart (British Cardiac Society), 2004, Volume: 90, Issue:8

    Topics: Antiparkinson Agents; Cabergoline; Ergolines; Fibrosis; Humans; Male; Middle Aged; Parkinson Disease; Pericarditis, Constrictive; Pleura; Pulmonary Fibrosis

2004
[Constrictive pericarditis caused by carbergoline].
    Ugeskrift for laeger, 2006, Jun-26, Volume: 168, Issue:26-32

    Topics: Aged; Antiparkinson Agents; Cabergoline; Dopamine Agents; Ergolines; Humans; Male; Pericarditis, Constrictive

2006
A case of constrictive pericarditis during cabergoline treatment for hyperprolactinaemia.
    European journal of endocrinology, 2008, Volume: 158, Issue:4

    Topics: Adult; Cabergoline; Dopamine Agonists; Dose-Response Relationship, Drug; Ergolines; Female; Humans; Hyperprolactinemia; Pericardiectomy; Pericarditis, Constrictive

2008
Constrictive pericarditis and pleuropulmonary disease linked to ergot dopamine agonist therapy (cabergoline) for Parkinson's disease.
    Mayo Clinic proceedings, 1999, Volume: 74, Issue:4

    Topics: Aged; Antiparkinson Agents; Cabergoline; Dopamine Agonists; Ergolines; Humans; Lung Diseases; Male; Parkinson Disease, Secondary; Pericarditis, Constrictive; Pleural Diseases; Tomography, X-Ray Computed

1999